Predisposing Factors and Consequences of Elevated Biomarker Levels in Long-Distance Runners Aged ≥55 Years

American Journal of Cardiology

Volumn 104, Issue 10, 2009, Pages 1434-1440

  Sahlén, Anders ^a   Gustafsson, Thomas P ^b   Svensson, Jan E ^b   Marklund, Tony ^c   Winter, Reidar ^a   Linde, Cecilia ^a   Braunschweig, Frieder ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c Roche Diagnostics Scandinavia   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE MARKER; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MARATHON RUNNER; PREDICTION; PRIORITY JOURNAL;

AGE FACTORS; BIOLOGICAL MARKERS; CREATININE; FEMALE; HEART DISEASES; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PHYSICAL ENDURANCE; RUNNING; TROPONIN T; WEIGHT LOSS;

EID: 71749101864     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.067     Document Type: Article

References (26)

1. Sahlen A., Winter R., Lind B., Jacobsen P.H., Stahlberg M., Marklund T., Fux T., Svensson J., and Braunschweig F. Magnitude, reproducibility, and association with baseline cardiac function of cardiac biomarker release in long-distance runners aged > or =55 years. Am J Cardiol 102 (2008) 218-222
2. Link M.S., and Nam III E. Ventricular arrhythmias. In: Nam III E., Salem D.N., and Wang P.J. (Eds). Sudden Cardiac Death in the Athlete (1998), Futura Publishing, Armonk, NY 253-275
3. Epstein S.E., and Maron B.J. Sudden death and the competitive athlete: perspectives on preparticipation screening studies. J Am Coll Cardiol 7 (1986) 220-230
4. Jokl P., Sethi P.M., and Cooper A.J. Master's performance in the New York City marathon 1983-1999. Br J Sports Med 38 (2004) 408-412
5. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
6. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., and Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
7. Herrmann M., Scharhag J., Miclea M., Urhausen A., Herrmann W., and Kindermann W. Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. Clin Chem 49 (2003) 831-834
8. Leers M.P., Schepers R., and Baumgarten R. Effects of a long-distance run on cardiac markers in healthy athletes. Clin Chem Lab Med 44 (2006) 999-1003
9. Neilan T.G., Januzzi J.L., Lee-Lewandrowski E., Ton-Nu T.T., Yoerger D.M., Jassal D.S., Lewandrowski K.B., Siegel A.J., Marshall J.E., Douglas P.S., Lawlor D., Picard M.H., and Wood M.J. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation 114 (2006) 2325-2333
10. La Gerche A., Connelly K.A., Mooney D.J., MacIsaac A.I., and Prior D.L. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart 94 (2008) 860-866
11. Sahlen A., Rubulis A., Winter R., Jacobsen P.H., Stahlberg M., Tornvall P., Bergfeldt L., and Braunschweig F. Cardiac fatigue in long-distance runners is associated with ventricular repolarization abnormalities. Heart Rhythm 6 (2009) 512-519
12. La Gerche A., Boyle A., Wilson A.M., and Prior D.L. No evidence of sustained myocardial injury following an ironman distance triathlon. Int J Sports Med 25 (2004) 45-49
13. Montgomery H.E., Clarkson P., Dollery C.M., Prasad K., Losi M.A., Hemingway H., Statters D., Jubb M., Girvain M., Varnava A., World M., Deanfield J., Talmud P., McEwan J.R., McKenna W.J., and Humphries S. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96 (1997) 741-747
14. Suzuki M., Sudoh M., Matsubara S., Kawakami K., Shiota M., and Ikawa S. Changes in renal blood flow measured by radionuclide angiography following exhausting exercise in humans. Eur J Appl Physiol Occup Physiol 74 (1996) 1-7
15. Hart E., Shave R., Middleton N., George K., Whyte G., and Oxborough D. Effect of preload augmentation on pulsed wave and tissue Doppler echocardiographic indices of diastolic function after a marathon. J Am Soc Echocardiogr 20 (2007) 1393-1399
16. Fortescue E.B., Shin A.Y., Greenes D.S., Mannix R.C., Agarwal S., Feldman B.J., Shah M.I., Rifai N., Landzberg M.J., Newburger J.W., and Almond C.S. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med 49 (2007) 137-143 143.e1
17. Scharhag J., Herrmann M., Urhausen A., Haschke M., Herrmann W., and Kindermann W. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 150 (2005) 1128-1134
18. Scharhag J., Urhausen A., Schneider G., Herrmann M., Schumacher K., Haschke M., Krieg A., Meyer T., Herrmann W., and Kindermann W. Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes. Eur J Cardiovasc Prev Rehabil 13 (2006) 388-397
19. Siegel A.J., Lewandrowski K.B., Strauss H.W., Fischman A.J., and Yasuda T. Normal post-race antimyosin myocardial scintigraphy in asymptomatic marathon runners with elevated serum creatine kinase MB isoenzyme and troponin T levels: evidence against silent myocardial cell necrosis. Cardiology 86 (1995) 451-456
20. Nikitin N.P., Witte K.K., Ingle L., Clark A.L., Farnsworth T.A., and Cleland J.G. Longitudinal myocardial dysfunction in healthy older subjects as a manifestation of cardiac ageing. Age Ageing 34 (2005) 343-349
21. Vinereanu D., Lim P.O., Frenneaux M.P., and Fraser A.G. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure-a comparison with brain natriuretic peptide. Eur J Heart Fail 7 (2005) 512-519
22. Nottin S., Nguyen L.D., Terbah M., and Obert P. Long-term endurance training does not prevent the age-related decrease in left ventricular relaxation properties. Acta Physiol Scand 181 (2004) 209-215
23. Johnston N., Jernberg T., Lindahl B., Lindback J., Stridsberg M., Larsson A., Venge P., and Wallentin L. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem 37 (2004) 210-216
24. Thompson P.D., Funk E.J., Carleton R.A., and Sturner W.Q. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 247 (1982) 2535-2538
25. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., Wolf P.A., and Vasan R.S. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
26. Devaraj S., Singh U., and Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 55 (2009) 229-238